MS
Morgan Stanley
MS has the edge over WRB overall, supported by stronger modeled upside and stronger fundamentals.
WRB
W. R. Berkley Corporation
WRB trails on the overall score without a compensating advantage in the available component scores.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
WRB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
WRB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like WRB.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
WRB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $66.55 | -14% |
| Fair | 15x | $72.25 | -6.4% |
| Current | 16x | $77.15 | — |
| Forward | 16x | $77.15 | — |
| Expensive | 20x | $94.93 | +23% |
Historical ranges are pointers, not guarantees.
WRB has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over WRB on the outlook, with more favorable valuation and profitability expectations.
WRB Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for WRB, but weaker profitability.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the stronger earnings trend. Trailing diluted EPS is up 29% for MS versus WRB up 21%.
WRB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.77 | +0.9% |
| Q3 2024 | $3.90 | +18% |
| Q2 2024 | $3.81 | +26% |
| Q1 2024 | $3.75 | +45% |
| Q4 2023 | $3.37 | +2.4% |
| Q3 2023 | $3.30 | +6.8% |
| Q2 2023 | $3.03 | -4.1% |
| Q1 2023 | $2.59 | -22% |
| Q4 2022 | $3.29 | +35% |
WRB's earnings per share have climbed steadily: $4.73 over the past year, up 21% from the year before, and higher year over year for nine quarters in a row.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over WRB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over WRB on profitability, with a higher operating margin.
WRB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | -0.8% |
| Q2 2026 | $3.7B | +1.2% |
| Q1 2026 | $3.7B | +4% |
| Q4 2025 | $3.7B | +1.5% |
| Q3 2025 | $3.8B | +11% |
| Q2 2025 | $3.7B | +11% |
| Q1 2025 | $3.5B | +8.9% |
| Q4 2024 | $3.7B | +14% |
WRB's revenue has held roughly level: $3.7B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | -1.8 points |
| Q2 2026 | 15% | +1.3 points |
| Q1 2026 | 17% | +1.5 points |
| Q4 2025 | 15% | -4.5 points |
| Q3 2025 | 17% | +3.3 points |
| Q2 2025 | 14% | -0.5 points |
| Q1 2025 | 15% | -2.4 points |
| Q4 2024 | 20% | +4.3 points |
WRB's operating margin was 15% last quarter, down 1.8 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
WRB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $731.3M | -36% |
| Q2 2026 | $800M | +14% |
| Q1 2026 | $667.9M | -10% |
| Q4 2025 | $995.1M | +23% |
| Q3 2025 | $1.1B | -8.1% |
| Q2 2025 | $703.8M | -20% |
| Q1 2025 | $743.8M | -0.3% |
| Q4 2024 | $810M | +16% |
WRB has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
WRB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -467K shares |
| 1 year | -2.2% | -8.9M shares |
| 3 years | -5.9% | -24.7M shares |
| 5 years | -7.4% | -31.4M shares |
WRB has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $21.1M |
| Q2 2026 | $111.5M |
| Q1 2026 | $302.4M |
| Q4 2025 | $196.4M |
| Q3 2025 | $24.6M |
| Q2 2025 | — |
| Q1 2025 | $49.2M |
| Q4 2024 | $67.4M |
WRB spent $631M buying back its own shares over the past year, about four times what it spent the year before.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
WRB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.0x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
WRB has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
WRB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.4 | Neutral |
| Stochastic | 73.6 | Neutral |
WRB's weekly RSI is 63 (neutral) and its Stochastic is 74 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over WRB on valuation relative to its sector.
WRB PE vs Financial Services Sector
| Metric | WRB | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 25% above |
| PE % | 66 | 63 | 3 pts above |
WRB is trading at 16x earnings, a 25% premium to the Financial Services sector's median of 13x.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
WRB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.8 | 5.9% above |
| 20 week MA | $71.7 | 7.5% above |
| 50 week MA | $69.5 | 11% above |
| 100 week MA | $69.3 | 11% above |
| 200 week MA | $59.3 | 30% above |
WRB has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
WRB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.5 | $29.4 | -3.6% |
| 2021 | $29.4 | $35.6 | +21% |
| 2022 | $35.6 | $49.0 | +37% |
| 2023 | $49.0 | $47.2 | -3.7% |
| 2024 | $47.2 | $59.0 | +25% |
| 2025 | $59.0 | $70.6 | +20% |
| 2026 YTD | $70.6 | $77.2 | +9.3% |
WRB has the edge over MS on returns for 2026, with the stronger performance.